BioSpace News Archive

This partnership will leverage Virtusa’s vLife open innovation platform to enable organizations to work in a connected ecosystem that allows them to access, validate, and adopt other firms’ technologies and enhance the entire research and development process.

LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that it has added Emmaus Life Sciences (Emmaus) to its client roster.

McCann Health, two-time Network of the Year winner at Cannes Lions Health, announced today that it has won Most Awarded Network 2018 at the Creative Floor Healthcare Awards celebrating the world’s best health and wellness creative work.

Significant Addition to Rapidly Expanding Portfolio of Intellectual Property (IP)

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342.

National Osteoporosis Foundation (NOF), the nation’s leading health organization solely dedicated to osteoporosis and bone health, announced the addition of two thoughtful new leaders to its newly designated Mission department, underscoring the organization’s commitment to delivering quality educational programming for patients and healthcare professionals

What would you say if you were told a preventative measure to being diagnosed with Alzheimer’s disease or dementia is sitting in your kitchen pantry? According to Auburn University Harrison School of Pharmacy researcher Dr. Amal Kaddoumi, that could certainly be the case.

Addus HomeCare Corporation will participate in the Credit Suisse 27th Annual Healthcare Conference, which takes place November 12-15, 2018, in Scottsdale, Arizona.

CEI Vision Partners announces Carl Berglind has been named Vice President of Mergers and Acquisitions. He will lead CVP’s newly formed M&A function.

Awareness programs by non-profit organization about the actinic keratosis treatment have increased the awareness level among the people about the actinic keratosis treatment in developed economies, which is consequently expected to increase the value of actinic keratosis treatment market